- Filed
- Mar 12, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Mar 5, 2026 | 64.07M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2026 | 64.23M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2026 | 65.25M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2025 | 66.96M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2025 | 67.86M sh |
| Stock Repurchased | Q3 2026 · Jan 31, 2026 | $5.47M |
| Stock Repurchased | Q3 2026 · Jan 31, 2025 | $1.5M |
| Capex | Q3 2026 · Jan 31, 2026 | $4.75M |
| Capex | Q3 2026 · Jan 31, 2025 | $6.14M |
| Operating Cash Flow | Q3 2026 · Jan 31, 2026 | $24.51M |
| Operating Cash Flow | Q3 2026 · Jan 31, 2025 | $19.58M |
| Long Term Debt | Q3 2026 · Jan 31, 2026 | $25.58M |
| Long Term Debt | Q3 2026 · Apr 30, 2025 | $29.87M |
| Short Term Debt | Q3 2026 · Jan 31, 2026 | $5.25M |
| Short Term Debt | Q3 2026 · Apr 30, 2025 | $5.29M |
| Cash And Equivalents | Q3 2026 · Jan 31, 2026 | $36.49M |
| Cash And Equivalents | Q3 2026 · Apr 30, 2025 | $25.23M |
| Stockholders Equity | Q3 2026 · Jan 31, 2026 | $76.34M |
| Stockholders Equity | Q3 2026 · Oct 31, 2025 | $70.21M |
| Stockholders Equity | Q3 2026 · Jul 31, 2025 | $65.24M |
| Stockholders Equity | Q3 2026 · Apr 30, 2025 | $65.11M |
| Stockholders Equity | Q3 2026 · Jan 31, 2025 | $62.37M |
| Stockholders Equity | Q3 2026 · Oct 31, 2024 | $59.06M |
| Stockholders Equity | Q3 2026 · Jul 31, 2024 | $56.29M |
| Stockholders Equity | Q3 2026 · Apr 30, 2024 | $54.44M |
| Current Liabilities | Q3 2026 · Jan 31, 2026 | $35.21M |
| Current Liabilities | Q3 2026 · Apr 30, 2025 | $24.41M |
| Total Liabilities | Q3 2026 · Jan 31, 2026 | $64.64M |
| Total Liabilities | Q3 2026 · Apr 30, 2025 | $58.18M |
| Current Assets | Q3 2026 · Jan 31, 2026 | $66.36M |
| Current Assets | Q3 2026 · Apr 30, 2025 | $47.31M |
| Total Assets | Q3 2026 · Jan 31, 2026 | $140.98M |
| Total Assets | Q3 2026 · Apr 30, 2025 | $123.3M |
| Eps Diluted | Q3 2026 · Jan 31, 2026 | $0.10 |
| Eps Diluted | Q3 2026 · Jan 31, 2026 | $0.25 |
| Eps Diluted | Q3 2026 · Jan 31, 2025 | $0.05 |
| Eps Diluted | Q3 2026 · Jan 31, 2025 | $0.14 |
| Eps Basic | Q3 2026 · Jan 31, 2026 | $0.10 |
| Eps Basic | Q3 2026 · Jan 31, 2026 | $0.25 |
| Eps Basic | Q3 2026 · Jan 31, 2025 | $0.05 |
| Eps Basic | Q3 2026 · Jan 31, 2025 | $0.14 |
| Rd Expense | Q3 2026 · Jan 31, 2026 | $1.04M |
| Rd Expense | Q3 2026 · Jan 31, 2025 | $1.59M |
| Net Income | Q3 2026 · Jan 31, 2026 | $6.7M |
| Net Income | Q3 2026 · Jan 31, 2026 | $16.38M |
| Net Income | Q3 2026 · Oct 31, 2025 | $5.99M |
| Net Income | Q3 2026 · Jul 31, 2025 | $3.69M |
| Net Income | Q3 2026 · Jan 31, 2025 | $3.38M |
| Net Income | Q3 2026 · Jan 31, 2025 | $9.22M |
| Net Income | Q3 2026 · Oct 31, 2024 | $3.6M |
| Net Income | Q3 2026 · Jul 31, 2024 | $2.25M |
| Operating Income | Q3 2026 · Jan 31, 2026 | $9.24M |
| Operating Income | Q3 2026 · Jan 31, 2026 | $20.98M |
| Operating Income | Q3 2026 · Jan 31, 2025 | $4.03M |
| Operating Income | Q3 2026 · Jan 31, 2025 | $12.42M |